Washington Legislative Update

Jenna Stern, Associate Vice President of Regulatory Affairs & Public Policy, supports Vizient’s government relations, monitors federal regulatory and legislative developments, and helps communicate Vizient’s positions on developments most relevant to Vizient and its members. Prior to joining Vizient, Jenna served as the Director of Health Policy for the American Pharmacists Association and as a senior associate with Avalere, a DC-based healthcare consulting firm.

Jenna received her law degree with a concentration in health law from Case Western Reserve University and is a member of the Maryland bar. She is also a graduate of Brock University where she received her bachelor of science in health sciences.

Jenna Stern, Associate VP of Regulatory Affairs & Public Policy at Vizient provides overview of presentation.
Jenna Stern, Associate VP of Regulatory Affairs & Public Policy at Vizient provides overview of presentation.

LEARNING OBJECTIVES

• Describe actions Congress and the Administration have recently taken related to the pharmaceutical supply chain and drug pricing
• Give examples of steps government agencies have taken given the May 11, 2023 end to the COVID-19 public health emergency
• Discuss anticipated federal legislative and regulatory issues that will impact pharmacists for the year ahead

Latest Videos
View all Videos
Executive Insights
Feb 10, 2025

Michael LaFauci, the CEO of MIDAS Healthcare Solutions, leads a company dedicated to the intelligent disposal and visual accountability of medications. MIDAS aims to ensure proof of final destruction of medications, enhancing safety for both patients and healthcare workers.  With a focus on teamwork and the right talent, MIDAS plans to expand its services across the hospital and retail sectors, ensuring proof throughout the medication chain of custody.

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.

Executive Insights
Jan 28, 2025

Venita Abanaka, the Director of Acute Care and Oncology at Parkland Health in Dallas, Texas, is dedicated to serving the underserved in a nearly thousand-bed hospital system. She is focused on redesigning acute care and clinical pharmacy, with an emphasis on automation and networking with vendors and colleagues. Venita values building the next generation of leaders and promotes a culture of servant leadership within her team. Despite challenges like fluid shortages, she views problems as opportunities and maintains a positive relationship with Health Connect Partners.